BioNTech Statistics
NASDAQ: BNTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
80.96-0.42 (-0.52%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BioNTech by the numbers
BioNTech has a market capitalization of $20.07 billion based on 247.93M shares outstanding. With trailing EPS of $-6.83, BioNTech is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.5% below its 50-day average and 14.9% below its 200-day average.
Average daily trading volume is 1.08M shares, or about $87.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BNTX valuation vs. peer median
| Metric | BNTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $20.07B | $10.44B | +92% |
| Avg. volume | 1.08M | 1.81M | -40% |
Peer median across 8 companies: EXEL, NBIX, TECH, RGEN, HALO, QGEN, KYMR, KRYS.
Valuation
- Market cap
- $20.07B
- EPS (TTM)
- $-6.83
- Shares outstanding
- 247.93M
Price and trading
- Previous close
- 81.38
- Open
- 80.79
- Day range
- 80.27 – 82.87
- 52-week range
- 79.52 – 124.00
- 52-week change
- -15.30%
- Beta
- —
- Volume
- 1.71M
- Average volume
- 1.08M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 20.07B
- Forward Pe
- -15.25
- Eps
- -6.83
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 124.00
- Week52 Low
- 79.52
- Avg Volume
- 1.08M
- Shares Outstanding
- 247.93M
- Ma50
- 91.52
- Ma200
- 95.09
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -34.71%
- Pct From52w Low
- 1.81%